shutterstock_650427094_edited.jpg
 

September 26, 2022 

AmMax Bio Announces Oral Presentation of Phase 2 Data of AMB-05X...

REDWOOD CITY, Calif. Nov 18, 2022 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

September 7, 2022 

AmMax Bio Announces AMB-05X Granted FDA Fast Track Designation...

REDWOOD CITY, Calif. Sep 7, 2022 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

February 24, 2022 

AmMax Bio Announces the Appointment of Biotechnology...

REDWOOD CITY, Calif. February 24, 2022 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

October 20, 2021 

AmMax Bio Announces Positive Interim Phase 2 Results of AMB-05X...

RREDWOOD CITY, Calif. October 20, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biotech company developing ...

April 29, 2021 

AmMax Bio to Present at the BofA Securities 2021 Virtual Healthcare...

RREDWOOD CITY, Calif. Apr. 29, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

March 30, 2020 

LifeMax Launches AmMax Bio Following The License Of Worldwide Rights...

Redwood City, California – (Business Wire) – March 30, 2020 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...

September 26, 2022 

AmMax Bio Provides Update on AMB-05X Program for...

REDWOOD CITY, Calif. Sep 26, 2022 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

July 25, 2022 

AmMax Bio Announces the Appointment of Dorothy  Nguyen, M.D. as...

REDWOOD CITY, Calif. July 25, 2022 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

December 7, 2021 

KOL Webinar REPLAY: Forging a New Standard of care in TCGT

The webinar featured presentations by two tenosynovial giant cell tumor experts from Leiden University Medical Center.

July 14, 2021 

AmMax Bio to Present at the 2nd Annual LifeSci Partners Private...

RREDWOOD CITY, Calif. July 14, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

March 2, 2021 

AmMax Bio Announces the Appointment of Biotechnology Executive...

REDWOOD CITY, Calif. March 2, 2021 — AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

September 12, 2022 

AmMax Bio Announces Presentation of Phase 2 PK/PD Data of...

REDWOOD CITY, Calif. Sep 12, 2022 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

March 2, 2022 

AmMax Bio Announces Positive Phase 2 Results Demonstrating...

REDWOOD CITY, Calif. March 2, 2022 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

November 30, 2021 

AmMax Bio Hosting Key Opinion Leader Webinar on AMB-05X for the...

REDWOOD CITY, Calif. Nov 30, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biotech company developing ...

May 26, 2021 

AmMax Bio Announces First Patient Enrolled in Phase 2 Trial of AMB-05X...

RREDWOOD CITY, Calif. May 26, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...

February 16, 2021 

AmMax Bio to Participate in the 41st Annual Cowen Health Care Conference

REDWOOD CITY, Calif. February 16, 2021 — AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...